New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 8, 2013
10:12 EDTBMY, MDCOThe Medicines Co. and Bristol-Myers' Recothrom collaboration becomes effective
The Medicines Company (MDCO) announced that the global license and two-year collaboration for Recothrom, a recombinant thrombin approved by the FDA for use as a topical hemostat to control non-arterial bleeding during surgical procedures, established with Bristol-Myers Squibb Company (BMY), has become effective. The agreement was first announced in December 2012. The companies have satisfied all required regulatory and closing conditions.
News For MDCO;BMY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 30, 2015
11:31 EDTBMYLion Biotechnologies TIL combo data an 'important' positive, says Piper Jaffray
After Lion Biotechnologies (LBIO) announced the report of positive results from a pilot trial of tumor infiltrating lymphocytes, or TIL, in combination with Bristol-Myers' (BMY) Yervoy in patients with metastatic melanoma, Piper Jaffray noted that the success rate for receiving TIL combo treatment was significantly higher than the prior result for TIL monontherapy. Piper said this fact highlights the combo approach may drive significantly broader application of TIL than it initially expected and the firm reiterated its Overweight rating and $21 price target on Lion shares.
07:05 EDTMDCOThe Medicines Co. receives EC approval for three hospital acute care products
Subscribe for More Information
March 27, 2015
08:44 EDTMDCOThe Medicines Co. has a conference call hosted by JPMorgan
Subscribe for More Information
06:08 EDTMDCOThe Medicines Co. assumed with a Neutral at Citigroup
Target $30.
March 26, 2015
07:30 EDTBMYDeutsche Bank to hold a conference
Pharma One-on-One Day is being held in Denver, Colorado on March 26.
March 25, 2015
07:12 EDTMDCOAmerican Academy of Orthopedic Surgeons to hold annual meeting
Subscribe for More Information
March 24, 2015
08:02 EDTBMYBristol-Myers acquires exclusive license from Novo Nordisk for research program
Subscribe for More Information
March 20, 2015
10:00 EDTMDCOOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:55 EDTBMYAstraZeneca seen as potential target again if oncology drugs lag, Bloomberg says
Subscribe for More Information
March 19, 2015
16:06 EDTMDCOThe Medicines Co. initiated with a Neutral at Mizuho
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use